British Columbia Investment Management Corp Qiagen N.V. Transaction History

British Columbia Investment Management Corp

$14.3 Billion
Q1 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 10, 2023	SELL	$41.91 - $50.48 $2,179 - $2,624	-52 Reduced 0.86%	5,990 $298,000
Q3 2022 Nov 10, 2022	BUY	$40.9 - $50.42 $247,117 - $304,637	6,042 New	6,042 $255,000

Others Institutions Holding QGEN

# of Institutions

Shares Held

6.76M

Call Options Held

Put Options Held

Pendal Group LTD

4.3M
Shares

$173 Million
1.76% of portfolio
Abeille Asset Management Sa

931K
Shares

$37.5 Million
1.68% of portfolio
Grandeur Peak Global Advisors, LLC Salt Lake City, UT

768K
Shares

$30.9 Million
2.68% of portfolio
Nuveen Asset Management, LLC Chicago, IL

345K
Shares

$13.9 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

153K
Shares

$6.18 Million
0.01% of portfolio

View Full List

About QIAGEN N.V.

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.16B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

More about QGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Account